Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mifepristone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Phase III Randomized Double-Blind Trial of Mifepristone vs Placebo for Unresectable Meningioma (Summary Last Modified 10/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9005, E-S9005
Phase II Study of Mifepristone (RU486) in Women with Hormone-Responsive Metastatic Breast Cancer (Summary Last Modified 09/94)
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: LBMMC-05193, NCI-V94-0462
Phase II Study of Mifepristone in Persistent or Recurrent Epithelial Ovarian Carcinoma (Summary Last Modified 07/97)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: Other
Protocol IDs: CH-RP-9368, NCI-V95-0711
Phase II Study of the Antiprogestational Agent RU486 in Patients with Unresectable Meningioma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: LAC-USC-6M871, NCI-V87-0233
Phase II Study of the Progesterone Antagonist Mifepristone in Postmenopausal Patients with Stage IV Breast Cancer (Summary Last Modified 01/95)
Phase: Phase II
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CAN-NCIC-IND73, NCI-V92-0088, IND73
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 04-249, NCT00140478
Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GOG-0170K, NCT00459290
Mifepristone for Patients With Endometrial Cancer and LGESS
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID01-212, NCT00505739
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-0546, NCI-2011-03525, NCT01493310
Start Over